75 related articles for article (PubMed ID: 38429437)
21. Conventional and unconventional interactions of the transcription factor FOXL2 uncovered by a proteome-wide analysis.
Penrad-Mobayed M; Perrin C; Herman L; Todeschini AL; Nigon F; Cosson B; Caburet S; Veitia RA
FASEB J; 2020 Jan; 34(1):571-587. PubMed ID: 31914586
[TBL] [Abstract][Full Text] [Related]
22. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
Cluzet V; Devillers MM; Petit F; Chauvin S; François CM; Giton F; Genestie C; di Clemente N; Cohen-Tannoudji J; Guigon CJ
Oncogene; 2020 Feb; 39(9):1875-1890. PubMed ID: 31745296
[TBL] [Abstract][Full Text] [Related]
23. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions.
Han H; Cho JW; Lee S; Yun A; Kim H; Bae D; Yang S; Kim CY; Lee M; Kim E; Lee S; Kang B; Jeong D; Kim Y; Jeon HN; Jung H; Nam S; Chung M; Kim JH; Lee I
Nucleic Acids Res; 2018 Jan; 46(D1):D380-D386. PubMed ID: 29087512
[TBL] [Abstract][Full Text] [Related]
24. Multiscale 3D Genome Rewiring during Mouse Neural Development.
Bonev B; Mendelson Cohen N; Szabo Q; Fritsch L; Papadopoulos GL; Lubling Y; Xu X; Lv X; Hugnot JP; Tanay A; Cavalli G
Cell; 2017 Oct; 171(3):557-572.e24. PubMed ID: 29053968
[TBL] [Abstract][Full Text] [Related]
25. Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer.
Walerych D; Lisek K; Sommaggio R; Piazza S; Ciani Y; Dalla E; Rajkowska K; Gaweda-Walerych K; Ingallina E; Tonelli C; Morelli MJ; Amato A; Eterno V; Zambelli A; Rosato A; Amati B; Wiśniewski JR; Del Sal G
Nat Cell Biol; 2016 Aug; 18(8):897-909. PubMed ID: 27347849
[TBL] [Abstract][Full Text] [Related]
26. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.
Kuleshov MV; Jones MR; Rouillard AD; Fernandez NF; Duan Q; Wang Z; Koplev S; Jenkins SL; Jagodnik KM; Lachmann A; McDermott MG; Monteiro CD; Gundersen GW; Ma'ayan A
Nucleic Acids Res; 2016 Jul; 44(W1):W90-7. PubMed ID: 27141961
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional genome architecture: players and mechanisms.
Pombo A; Dillon N
Nat Rev Mol Cell Biol; 2015 Apr; 16(4):245-57. PubMed ID: 25757416
[TBL] [Abstract][Full Text] [Related]
28. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping.
Rao SS; Huntley MH; Durand NC; Stamenova EK; Bochkov ID; Robinson JT; Sanborn AL; Machol I; Omer AD; Lander ES; Aiden EL
Cell; 2014 Dec; 159(7):1665-80. PubMed ID: 25497547
[TBL] [Abstract][Full Text] [Related]
29. FOXL2: a central transcription factor of the ovary.
Georges A; Auguste A; Bessière L; Vanet A; Todeschini AL; Veitia RA
J Mol Endocrinol; 2014 Feb; 52(1):R17-33. PubMed ID: 24049064
[TBL] [Abstract][Full Text] [Related]
30. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.
Chen EY; Tan CM; Kou Y; Duan Q; Wang Z; Meirelles GV; Clark NR; Ma'ayan A
BMC Bioinformatics; 2013 Apr; 14():128. PubMed ID: 23586463
[TBL] [Abstract][Full Text] [Related]
31. Essential but differential role of FOXL2wt and FOXL2C134W in GDF-9 stimulation of follistatin transcription in co-operation with Smad3 in the human granulosa cell line COV434.
Nonis D; McTavish KJ; Shimasaki S
Mol Cell Endocrinol; 2013 Jun; 372(1-2):42-8. PubMed ID: 23523567
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.
Cheng JC; Klausen C; Leung PC
PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819
[TBL] [Abstract][Full Text] [Related]
33. The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
Rosario R; Araki H; Print CG; Shelling AN
PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457
[TBL] [Abstract][Full Text] [Related]
34. Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation.
Benayoun BA; Anttonen M; L'Hôte D; Bailly-Bechet M; Andersson N; Heikinheimo M; Veitia RA
Oncogene; 2013 May; 32(22):2739-46. PubMed ID: 22797072
[TBL] [Abstract][Full Text] [Related]
35. A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation.
Shih HP; Kopp JL; Sandhu M; Dubois CL; Seymour PA; Grapin-Botton A; Sander M
Development; 2012 Jul; 139(14):2488-99. PubMed ID: 22675211
[TBL] [Abstract][Full Text] [Related]
36. Topological domains in mammalian genomes identified by analysis of chromatin interactions.
Dixon JR; Selvaraj S; Yue F; Kim A; Li Y; Shen Y; Hu M; Liu JS; Ren B
Nature; 2012 Apr; 485(7398):376-80. PubMed ID: 22495300
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis of granulosa cell tumors of the ovary.
Jamieson S; Fuller PJ
Endocr Rev; 2012 Feb; 33(1):109-44. PubMed ID: 22240241
[TBL] [Abstract][Full Text] [Related]
38. Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis.
Richards JS; Fan HY; Liu Z; Tsoi M; Laguë MN; Boyer A; Boerboom D
Oncogene; 2012 Mar; 31(12):1504-20. PubMed ID: 21860425
[TBL] [Abstract][Full Text] [Related]
39. Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.
Yadav H; Quijano C; Kamaraju AK; Gavrilova O; Malek R; Chen W; Zerfas P; Zhigang D; Wright EC; Stuelten C; Sun P; Lonning S; Skarulis M; Sumner AE; Finkel T; Rane SG
Cell Metab; 2011 Jul; 14(1):67-79. PubMed ID: 21723505
[TBL] [Abstract][Full Text] [Related]
40. Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma.
Ohishi Y; Oda Y; Kurihara S; Kaku T; Kobayashi H; Wake N; Tsuneyoshi M
Histopathology; 2011 Feb; 58(3):423-32. PubMed ID: 21299609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
